A Phase 4, Observational Study Evaluating the Efficacy and Safety of the Bruton Tyrosine Kinase Inhibitor (BTKi) Zanubrutinib in Patients with Waldenstrom Macroglobulinemia (WM)Edwin C. Kingsley, Shannon Fabre, Motohisa Takai,Aileen Cleary Cohen, Jingjing Schneider,Jessica Li, James D'OlimpioBLOOD（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
